Mechanisms of topoisomerase I inhibition by anticancer drugs.

[1]  K. Kohn,et al.  Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[3]  Y. Pommier,et al.  Eukaryotic DNA topoisomerases I. , 1995, Biochimica et biophysica acta.

[4]  Y. Cheng,et al.  Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity. , 1995, Molecular pharmacology.

[5]  E. Louis,et al.  Sgs1: A eukaryotic homolog of E. coil RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation , 1995, Cell.

[6]  L. Liu,et al.  Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I. , 1995, Experimental cell research.

[7]  D. Toppmeyer,et al.  A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  M. Wani,et al.  Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. , 1995, Cancer research.

[9]  D. Averbeck,et al.  Comparison of the effects of DNA topoisomerase inhibitors on lymphoblasts from normal and Fanconi anemia donors. , 1994, Mutation research.

[10]  S Gangloff,et al.  The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase , 1994, Molecular and cellular biology.

[11]  A. Fornace,et al.  The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.

[12]  J. M. Murcia,et al.  Poly(ADP-ribose) polymerase: a molecular nick-sensor. , 1994, Trends in biochemical sciences.

[13]  M. Kastan,et al.  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways , 1994, Molecular and cellular biology.

[14]  R. Roeder,et al.  Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Liu,et al.  Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. , 1993, Cancer research.

[16]  S. Ellard,et al.  Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells. , 1993, Carcinogenesis.

[17]  Y. Pommier,et al.  Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials. , 1993, Molecular pharmacology.

[18]  D. Reinberg,et al.  DNA topoisomerase I is involved in both repression and activation of transcription , 1993, Nature.

[19]  R. Slebos,et al.  Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. , 1993, Cancer research.

[20]  H. Strutt,et al.  Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA. , 1993, Cancer research.

[21]  S. Korsmeyer,et al.  Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. , 1993, Cancer research.

[22]  M. Poot,et al.  DNA topoisomerases and the DNA lesion in human genetic instability syndromes. , 1993, Toxicology letters.

[23]  Y. Pommier,et al.  Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells. , 1992, European journal of cancer.

[24]  Y. Pommier,et al.  Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture. , 1992, Cancer research.

[25]  D. Kufe,et al.  Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells. , 1991, Cancer research.

[26]  K. Kohn,et al.  Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. , 1991, Nucleic acids research.

[27]  G. Hofmann,et al.  Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). , 1991, Cancer research.

[28]  J. Riou,et al.  Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives. , 1991, Molecular pharmacology.

[29]  K W Kohn,et al.  Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. , 1991, The Journal of biological chemistry.

[30]  T. Andoh,et al.  Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. , 1991, Cancer research.

[31]  P. Jeggo,et al.  Cross-sensitivity of γ-ray-sensitive hamster mutants to cross-linking agents , 1991 .

[32]  H. Kuga,et al.  Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. , 1991, Cancer research.

[33]  K. Kohn,et al.  S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells. , 1991, Cancer communications.

[34]  H. Strutt,et al.  Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. , 1991, Nucleic acids research.

[35]  H. Nakano,et al.  Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. , 1991, Biochemistry.

[36]  K S Sellins,et al.  Hyperthermia induces apoptosis in thymocytes. , 1991, Radiation research.

[37]  U. Mortensen,et al.  Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature. , 1991, Nucleic acids research.

[38]  S. Kaufmann,et al.  Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line. , 1991, Cancer research.

[39]  J. Boehm,et al.  Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity , 1991 .

[40]  K. Kohn,et al.  Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin. , 1990, Nucleic acids research.

[41]  R. Hertzberg,et al.  Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site. , 1990, The Journal of biological chemistry.

[42]  L. Liu,et al.  Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. , 1990, Cancer research.

[43]  N. Saijo,et al.  Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance. , 1990, Cancer research.

[44]  A. Amadei,et al.  Regulation of the function of eukaryotic DNA topoisomerase I: analysis of the binding step and of the catalytic constants of topoisomerization as a function of DNA topology. , 1990, Biochemistry.

[45]  P. Caron,et al.  The role of DNA topoisomerases in recombination and genome stability: A double-edged sword? , 1990, Cell.

[46]  K. Lund,et al.  Minimal DNA duplex requirements for topoisomerase I-mediated cleavage in vitro. , 1990, The Journal of biological chemistry.

[47]  K. Kohn,et al.  Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. , 1990, Molecular pharmacology.

[48]  C. Bendixen,et al.  Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. , 1990, Biochemistry.

[49]  Y. Pommier,et al.  Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C. , 1990, The Journal of biological chemistry.

[50]  U. Mortensen,et al.  Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis. , 1990, Nucleic acids research.

[51]  R. Snapka,et al.  Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks. , 1990, Biochemical and biophysical research communications.

[52]  A. Richter,et al.  Expression of the topoisomerase I gene in serum stimulated human fibroblasts. , 1990, Biochimica et biophysica acta.

[53]  T. Furuta,et al.  Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. , 1990, Cancer research.

[54]  J. Thacker,et al.  DNA-break repair, radioresistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia-telangiectasia cells. , 1990, Mutation research.

[55]  K. Kohn,et al.  Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin. , 1990, Journal of medicinal chemistry.

[56]  R. Herrera,et al.  Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities , 1990, Cell.

[57]  J. Champoux.  6 Mechanistic Aspects of Type-I Topoisomerases , 1990 .

[58]  G. Gianfranceschi,et al.  Phosphorylation sites for type N II protein kinase in DNA-topoisomerase I from calf thymus. , 1990, The International journal of biochemistry.

[59]  K. Kohn,et al.  10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells. , 1990, Cancer communications.

[60]  D. Samuels,et al.  Protein kinase C phosphorylates DNA topoisomerase I , 1989, FEBS letters.

[61]  Y. Pommier,et al.  Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. , 1989, Cancer research.

[62]  J. Wang,et al.  Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. , 1989, Cancer research.

[63]  J. Champoux,et al.  The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. , 1989, Nucleic acids research.

[64]  P. Kroeger,et al.  Interaction of topoisomerase 1 with the transcribed region of the Drosophila HSP 70 heat shock gene. , 1989, Nucleic acids research.

[65]  A. Amadei,et al.  In vitro preferential topoisomerization of bent DNA. , 1989, Nucleic acids research.

[66]  L. Liu,et al.  Poly(ADP-ribose)-mediated post-translational modification of chromatin-associated human topoisomerase I. Inhibitory effects on catalytic activity. , 1989, The Journal of biological chemistry.

[67]  K. Kohn,et al.  Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. , 1989, Cancer research.

[68]  L. Liu,et al.  Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.

[69]  S. Chatterjee,et al.  Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability. , 1989, Experimental cell research.

[70]  L. Liu,et al.  DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. , 1989, Cancer research.

[71]  U. Mortensen,et al.  Interactions between eukaryotic DNA topoisomerase I and a specific binding sequence. , 1989, The Journal of biological chemistry.

[72]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[73]  R. Hertzberg,et al.  In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. , 1989, Cancer research.

[74]  J. Wang,et al.  Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[75]  K. Kohn,et al.  Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. , 1989, Cancer research.

[76]  P. Cerutti,et al.  ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6. , 1989, Biochemistry.

[77]  R. Hertzberg,et al.  Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. , 1989, Journal of medicinal chemistry.

[78]  J. Champoux,et al.  Mapping in vivo topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules , 1989, Molecular and cellular biology.

[79]  P. Smith,et al.  Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with the expression of DNA topoisomerase I. , 1989, International journal of radiation biology.

[80]  J. Champoux,et al.  The effects of camptothecin on the reaction and the specificity of the wheat germ type I topoisomerase. , 1989, The Journal of biological chemistry.

[81]  S. Chatterjee,et al.  Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. , 1989, Cancer communications.

[82]  K. Kohn,et al.  Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin. , 1988, Nucleic acids research.

[83]  R. Sternglanz,et al.  Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. , 1988, Molecular pharmacology.

[84]  R. Hertzberg,et al.  Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. , 1988, Cancer research.

[85]  J. Wang,et al.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[86]  C. Perez-stable,et al.  Enrichment and depletion of Hela topoisomerase I recognition sites among specific types of DNA elements. , 1988, Nucleic acids research.

[87]  R. Knippers,et al.  Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks , 1988, Molecular and cellular biology.

[88]  E. Di Mauro,et al.  Eukaryotic DNA topoisomerase I reaction is topology dependent. , 1988, Nucleic acids research.

[89]  L. Bolund,et al.  Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage. , 1988, Journal of molecular biology.

[90]  R. Benbow,et al.  Regulation of Xenopus laevis DNA topoisomerase I activity by phosphorylation in vitro. , 1988, Biochemistry.

[91]  L. Liu,et al.  Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. , 1988, Cancer research.

[92]  L. Bolund,et al.  Characterization of a camptothecin-resistant human DNA topoisomerase I. , 1988, The Journal of biological chemistry.

[93]  M. Muller,et al.  Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[94]  V. Culotta,et al.  Sites of topoisomerase I action on X. laevis ribosomal chromatin: Transcriptionally active rDNA has an ∼200 bp repeating structure , 1988, Cell.

[95]  W. Earnshaw,et al.  Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Wang,et al.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[97]  T. Tanaka,et al.  Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors. , 1987, Cancer research.

[98]  G. Manikumar,et al.  Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure-activity correlations. , 1987, Journal of medicinal chemistry.

[99]  G. Schütz,et al.  Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene , 1987, Cell.

[100]  Y. Pommier,et al.  DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators. , 1987, Nucleic acids research.

[101]  Y. Suzuki,et al.  Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[102]  J. Wang.  Recent studies of DNA topoisomerases. , 1987, Biochimica et biophysica acta.

[103]  H. Blöcker,et al.  Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin. , 1987, The EMBO journal.

[104]  S. Jacob,et al.  Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[105]  S. Crooke,et al.  Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. , 1987, Cancer research.

[106]  L. Liu,et al.  Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[107]  S. Elgin,et al.  Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor camptothecin , 1987, Molecular and cellular biology.

[108]  D. Kroll,et al.  Camptothecin inhibits hsp 70 heat-shock transcription and induces DNA strand breaks in hsp 70 genes in Drosophila. , 1987, NCI monographs : a publication of the National Cancer Institute.

[109]  R. Snapka.  Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication. , 1986, Molecular and cellular biology.

[110]  J. Champoux,et al.  The role of single-strand breaks in the catenation reaction catalyzed by the rat type I topoisomerase. , 1986, The Journal of biological chemistry.

[111]  Y. Sugiura,et al.  Photosensitive DNA cleavage and phage inactivation by copper(II)-camptothecin. , 1986, Biochemistry.

[112]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[113]  M. Goodenough,et al.  Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells. , 1985, The EMBO journal.

[114]  J. Jongstra-Bilen,et al.  Inhibition of calf thymus type II DNA topoisomerase by poly(ADP‐ribosylation). , 1985, The EMBO journal.

[115]  O. Westergaard,et al.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in tetrahymena R-chromatin , 1985, Cell.

[116]  M. Muller,et al.  Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. , 1985, The EMBO journal.

[117]  M. Fukada.  Action of camptothecin and its derivatives on deoxyribonucleic acid. , 1985, Biochemical pharmacology.

[118]  M. Muller.  Quantitation of eukaryotic topoisomerase I reactivity with DNA. Preferential cleavage of supercoiled DNA. , 1985, Biochimica et biophysica acta.

[119]  J. Champoux,et al.  Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing. , 1984, Journal of molecular biology.

[120]  J. Wang,et al.  Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[121]  R. Burgess,et al.  Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. , 1984, Nucleic acids research.

[122]  B. Olivera,et al.  Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. , 1984, The Journal of biological chemistry.

[123]  M. C. McElwain,et al.  Poly(ADP-ribosylation) of DNA topoisomerase I: a nuclear response to DNA-strand interruptions. , 1984, Cold Spring Harbor symposia on quantitative biology.

[124]  L. Thompson,et al.  Poly (ADP-ribosylation) and DNA topoisomerase I in different cell lines. , 1984, Advances in experimental medicine and biology.

[125]  Y. Tse‐Dinh,et al.  Virus- and cell-encoded tyrosine protein kinases inactivate DNA topoisomerases in vitro , 1984, Nature.

[126]  P. Mandel,et al.  DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation). , 1983, European journal of biochemistry.

[127]  B. Olivera,et al.  Poly(ADP-ribosylation) of a DNA topoisomerase. , 1983, The Journal of biological chemistry.

[128]  H. Busch,et al.  Phosphorylation of purified Novikoff hepatoma topoisomerase I. , 1983, Biochemical and biophysical research communications.

[129]  M. Duguet,et al.  DNA topoisomerases from rat liver: physiological variations. , 1983, Nucleic acids research.

[130]  L. Liu,et al.  Intra- and intermolecular strand transfer by HeLa DNA topoisomerase I. , 1982, The Journal of biological chemistry.

[131]  K. Kohn,et al.  Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. , 1981, Biochemistry.

[132]  J. Champoux,et al.  The effect of salt on the binding of the eucaryotic DNA nicking-closing enzyme to DNA and chromatin. , 1981, Biochimica et biophysica acta.

[133]  J. Champoux.  DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine. , 1981, The Journal of biological chemistry.

[134]  J. Wang,et al.  Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA. , 1980, The Journal of biological chemistry.

[135]  Hutchinson Cr,et al.  Prodrug analogues of the antitumor alkaloid camptothecin. , 1979 .

[136]  J. Champoux.  Mechanism of the reaction catalyzed by the DNA untwisting enzyme: attachment of the enzyme to 3'-terminus of the nicked DNA. , 1978, Journal of molecular biology.

[137]  J. Champoux.  Strand breakage by the DNA untwisting enzyme results in covalent attachment of the enzyme to DNA. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[138]  J. Champoux.  Evidence for an intermediate with a single-strand break in the reaction catalyzed by the DNA untwisting enzyme. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Horwitz,et al.  Effects of camptothecin on the breakage and repair of DNA during the cell cycle. , 1973, Cancer research.

[140]  L. Li,et al.  Action of camptothecin on mammalian cells in culture. , 1972, Cancer research.

[141]  K. Kohn,et al.  Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells. , 1972, Molecular pharmacology.

[142]  D. Kessel,et al.  Camptothecin effects on DNA synthesis in murine leukemia cells. , 1972, Biochimica et biophysica acta.

[143]  J. Warner,et al.  Ribosome formation is blocked by camptothecin, a reversible inhibitor of RNA synthesis. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[144]  M. Horwitz,et al.  Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin. , 1971, Biochemical and biophysical research communications.

[145]  A. Grollman,et al.  Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. , 1971, Molecular pharmacology.

[146]  D. Kessel,et al.  Effects of camptothecin on RNA synthesis in leukemia L1210 cells. , 1971, Biochimica et biophysica acta.